Serum
Note only available to Consultant Obstetricians
pmol/L
Ovarian reserve AMH (pmol/L)
Very low <3
Low 3 – 8
Satisfactory 9 – 25
Optimal 26 – 40
High >40
Levels greater than 48.5 pmol/L may be suggestive of PCOS or Granulosa tumours
Evaluating Fertility Potential – Serum AMH levels correlate with the number of early antral follicles with greater specificity than Inhibin B, Oestradiol, Follicle Stimulating Hormone and Luteinizing Hormone on cycle day 3. Thus, Day 3 AMH may reflect ovarian follicular status better than these hormone markers.
Measuring Ovarian Aging – Diminished ovarian reserve, associated with poor response to IVF, is signaled by reduced baseline serum AMH concentrations. AMH would appear to be a useful marker for predicting ovarian aging and the potential for successful IVF.
Predicting Onset of Menopause – The duration of the menopausal transition can vary significantly in individuals and reproductive capacity may be seriously compromised prior to clinical diagnosis. AMH can predict the occurrence of the menopausal transition.
Assessing Polycystic Ovary Syndrome – Serum AMH levels are elevated in patients with polycystic ovary syndrome and may be useful as a marker for the extent of the disease.
In-house
7 days
Can be added on to an existing request up to 4 days following sample receipt
Please note this test is not UKAS accredited
Specimen Labelling Procedure
8210
